OpGen Inc
Change company Symbol lookup
Select an option...
OPGN OpGen Inc
THAR Tharimmune Inc
KITT Nauticus Robotics Inc
EAT Brinker International Inc
JCSE JE Cleantech Holdings Ltd
GVP GSE Systems Inc
CURV Torrid Holdings Inc
APRN Blue Apron Holdings Inc
BXRX Baudax Bio Inc
LAC Lithium Americas Corp

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value
Company profile

OpGen, Inc. (OpGen) is a precision medicine company that uses molecular diagnostics and informatics to combat infectious diseases. The Company, through its subsidiaries, is focused on developing and commercializing molecular microbiology solutions helping to guide clinicians with actionable information infections caused by multidrug-resistant microorganisms (MDROs). The Company’s product portfolio includes Unyvero, Acuitas AMR Gene Panel, and the ARES Technology Platform including ARESdb, next-generation sequencing (NGS) technology and AI-powered bioinformatics solutions for AMR surveillance, outbreak analysis, and antibiotic response prediction including ARESiss, ARESid, ARESasp, and AREScloud, as well as the Curetis CE- in vitro diagnostics (IVD)-marked polymerase chain reaction (PCR)-based severe acute respiratory syndrome (SARS)-CoV-2 test kit. The Company’s subsidiaries include Curetis GmbH and Ares Genetics GmbH.

Closing Price
Day's Change
0.1996 (99.30%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

Palantir Customers to Feature Artificial Intelligence Platform in Action at AIPCon, with 30+ Presentations and Demos

7:19 pm ET September 7, 2023 (BusinessWire) Print

Palantir Technologies Inc. (NYSE: PLTR) today announced its next AIPCon customer conference will be held on September 14 and live streamed online. AIPCon will feature more than 30 organizations showcasing how they use Palantir's new Artificial Intelligence Platform (AIP) to drive concrete business outcomes.

Introduced less than six months ago, Palantir AIP is already used by more than 100 organizations in sectors ranging from energy to finance, hospitality, and healthcare. AIPCon will bring together users of AIP to exchange with current and potential Palantir customers on best use cases and the transformational power of Palantir's AI technology.

AIPCon will also feature Palantir CEO Alex Karp, CTO Shyam Sankar, and Head of Global Commercial Ted Mabrey who will take the stage to give an in-depth look at Palantir AIP and specific examples of how customers are getting started quickly on their AI journey.

Customer keynotes at AIPCon will include:

CPKC HCA Healthcare Cintra Eaton SOMPO Japan Miller's Ale House

Additional customers such as Intuit, the New York Stock Exchange, Cone Health, Genpact and more will offer attendees Master Classes and demonstrations on the use of AIP, offering unprecedented insight into the workflow and capabilities of Palantir's AIP.

AIPCon will be accessible via live stream beginning at 9:00am PT on Thursday, September 14, 2023 on Palantir's YouTube channel. More information about AIP can be found here.

About Palantir Technologies Inc.

Foundational software of tomorrow. Delivered today. Additional information is available at https://www.palantir.com.

Forward-Looking Statements

This press release and the presentations to which it relates contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, Palantir's expectations regarding our product development, distribution, and pricing, expected benefits of and applications for our software platforms, business strategy and plans (including strategy and plans relating to our Artificial Intelligence Platform ("AIP"), sales and marketing efforts, partnerships, and customers), investments in our business, market trends and market size, expectations regarding any current or potential customers, partnerships, or other business relationships or initiatives, opportunities (including growth opportunities), and positioning, as well as assumptions relating to the foregoing. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Limited AIP trial access available now. Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include our ability to meet the unique needs of our customer; the failure of our platforms to satisfy our customer or perform as desired; the frequency or severity of any software and implementation errors; our platforms' reliability; and the timing of the development and release of, and updates to, our products. Additional information regarding these and other risks and uncertainties is included in the filings we make with the Securities and Exchange Commission from time to time. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230907499815/en/

SOURCE: Palantir Technologies Inc.">

Lisa Gordon
comtex tracking


Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.